Middle East & North Africa (IDA & IBRD countries) | Antiretroviral therapy coverage (% of people living with HIV)

Antiretroviral therapy coverage indicates the percentage of all people living with HIV who are receiving antiretroviral therapy. Limitations and exceptions: The limited availability of data on health status is a major constraint in assessing the health situation in developing countries. Surveillance data are lacking for many major public health concerns. Estimates of prevalence and incidence are available for some diseases but are often unreliable and incomplete. National health authorities differ widely in capacity and willingness to collect or report information. Statistical concept and methodology: Data on HIV are from the Joint United Nations Programme on HIV/AIDS (UNAIDS). Changes in procedures and assumptions for estimating the data and better coordination with countries have resulted in improved estimates of HIV and AIDS. Antiretroviral therapy has led to huge reductions in death and suffering of people with advanced HIV infection.
Publisher
The World Bank
Origin
Middle East & North Africa (IDA & IBRD countries)
Records
63
Source
Middle East & North Africa (IDA & IBRD countries) | Antiretroviral therapy coverage (% of people living with HIV)
year value
1960
1961
1962
1963
1964
1965
1966
1967
1968
1969
1970
1971
1972
1973
1974
1975
1976
1977
1978
1979
1980
1981
1982
1983
1984
1985
1986
1987
1988
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000 0.64301075
2001 0.88140162
2002 0.96165551
2003 1.99436574
2004 2.3183785
2005 2.94526445
2006 4.27831958
2007 4.86015831
2008 5.80677126
2009 7.32959102
2010 8.79968823
2011 10.89132587
2012 13.79312416
2013 16.48864057
2014 20.04313611
2015 24.49398907
2016 29.7346765
2017 34.01640474
2018 39.21925495
2019 42.19662847
2020 44.61637682
2021 47.1850975
2022

Middle East & North Africa (IDA & IBRD countries) | Antiretroviral therapy coverage (% of people living with HIV)

Antiretroviral therapy coverage indicates the percentage of all people living with HIV who are receiving antiretroviral therapy. Limitations and exceptions: The limited availability of data on health status is a major constraint in assessing the health situation in developing countries. Surveillance data are lacking for many major public health concerns. Estimates of prevalence and incidence are available for some diseases but are often unreliable and incomplete. National health authorities differ widely in capacity and willingness to collect or report information. Statistical concept and methodology: Data on HIV are from the Joint United Nations Programme on HIV/AIDS (UNAIDS). Changes in procedures and assumptions for estimating the data and better coordination with countries have resulted in improved estimates of HIV and AIDS. Antiretroviral therapy has led to huge reductions in death and suffering of people with advanced HIV infection.
Publisher
The World Bank
Origin
Middle East & North Africa (IDA & IBRD countries)
Records
63
Source